Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Interest Expenses (2020 - 2023)

Historic Interest Expenses for GeneDx Holdings (WGS) over the last 4 years, with Q2 2023 value amounting to $626000.0.

  • GeneDx Holdings' Interest Expenses fell 2075.95% to $626000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $626000.0, marking a year-over-year decrease of 8022.74%. This contributed to the annual value of $3.2 million for FY2022, which is 1312.17% up from last year.
  • GeneDx Holdings' Interest Expenses amounted to $626000.0 in Q2 2023, which was down 2075.95% from $767000.0 recorded in Q1 2023.
  • GeneDx Holdings' Interest Expenses' 5-year high stood at $808000.0 during Q1 2022, with a 5-year trough of $626000.0 in Q2 2023.
  • Over the past 4 years, GeneDx Holdings' median Interest Expenses value was $722500.0 (recorded in 2021), while the average stood at $726666.7.
  • In the last 5 years, GeneDx Holdings' Interest Expenses soared by 1800.88% in 2022 and then crashed by 2075.95% in 2023.
  • Quarter analysis of 4 years shows GeneDx Holdings' Interest Expenses stood at $648000.0 in 2020, then grew by 9.1% to $707000.0 in 2021, then increased by 13.58% to $803000.0 in 2022, then dropped by 22.04% to $626000.0 in 2023.
  • Its last three reported values are $626000.0 in Q2 2023, $767000.0 for Q1 2023, and $803000.0 during Q4 2022.